Net Margin - Lytix Biopharma AS (OSE:LYTIX) - Alpha Spread
L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 7.54 NOK -1.82% Market Closed
Market Cap: 374.1m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Net Margin
Lytix Biopharma AS

-2 202.4%
Current
-28 773%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 202.4%
=
Net Income
-87.9m
/
Revenue
4m

Net Margin Across Competitors

Country NO
Market Cap 374.1m NOK
Net Margin
-2 202%
Country US
Market Cap 341.9B USD
Net Margin
10%
Country US
Market Cap 180.5B USD
Net Margin
10%
Country US
Market Cap 127.8B USD
Net Margin
32%
Country US
Market Cap 123.3B USD
Net Margin
-5%
Country US
Market Cap 104.5B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.4B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for Lytix Biopharma AS.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 202.4%
=
Net Income
-87.9m
/
Revenue
4m
What is the Net Margin of Lytix Biopharma AS?

Based on Lytix Biopharma AS's most recent financial statements, the company has Net Margin of -2 202.4%.